Thermo Fisher to acquire molecular diagnostic company Mesa Biotech for up to $500m

Thermo Fisher Scientific has agreed to acquire California-based point-of-care molecular diagnostic company Mesa Biotech in a deal worth up to $500 million. The consideration includes ... Read More